/home/venatorx/public_html/dev.venatorx.com/wp-content/themes/venatorx3/header.php on line 43
">

In the News

December 10, 2019
The Philadelphia Inquirer
Malvern drugmaker is hopeful where others struggle: Fighting deadly ‘superbugs’
December 10, 2019
Infection Control Today
Governments Consider Funding Development of Breakthrough Antibiotics
December 2, 2019
WSJ Venture Capital
VC Daily: Venture Rounds Shrink; Antibiotics Startups Branch Out; Valor Equity’s New Fund
November 25, 2019
Philadelphia Business Journal
Malvern firm awarded $4.1M — and maybe more — to develop STD treatment
November 24, 2019
Antibiotics: 'The Perfect Storm' Blog
Innovation or Clinical Utility?
September 3, 2019
Daily Local News
Houlahan tours Malvern antibiotic drug facility
August 22, 2019
Homeland Preparedness News
HHS, DoD partner with Venatorx Pharmaceuticals on drug-resistant infection treatment
July 23, 2019
Beckers Hospital Review
HHS, DOD boost superbug fight with $97M investment: 4 things to know
July 22, 2019
Fierce Healthcare
HHS, DOD to pay up to $97M to help Venatorx target superbugs
July 22, 2019
Modern Healthcare
HHS, Defense to fund antibiotic development for drug-resistant infections
July 22, 2019
Philadelphia Business Journal
Exclusive: Antibiotics developer enters into $30.7M partnership to advance its ‘anti-superbug agent’
May 1, 2019
Nature
Interplay between beta-lactamases and new beta-lactamase inhibitors
April 5, 2019
Chemical and Engineering News
Drug structures displayed for the first time in Orlando
March 14, 2019
Philadelphia Business Journal
Life Sciences Pa. reveals awards for its top CEO, top products and deal of the year
Archive: 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
You are using a browser that is not supported. Please consider changing your browser